Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by davikingon Feb 18, 2014 11:06am

218 Views

Post# 22219954

RE:A "nut gather" for the squirrel

Hey som,
You seem to know a lot and can find all sorts of info.
Still haven't seen the source of your " In the EUPHRATES trial, it has been estimated that the current sample size of 360 patients would be equivalent to a similar study with 1,200 patients " comment.
It would be nice to get verification of who wrote that interesting piece.
TIA

Bullboard Posts

Eminent acquires promising Nevada gold project